Objective: Cystatin C is a novel marker of kidney function. Serum Cystatin C has been shown to correlate with the progression of prediabetes and type 2 diabetes mellitus. The aim of this study was to evaluate cystatin C levels in diabetic and prediabetic patients and determine its association with anthropometric measurements and insulin resistance.
INTRODUCTION
Type 2 diabetes is a disease which causes important morbidity, and mortality. Early intervention during prediabetic period may significantly delay or prevent development of type 2 diabetes. Adipose tissue is an important factor in the progression of prediabetes to diabetes. Epidemiologic studies have demonstrated an increase in cystatin C levels in obesity. [1] Cystatin C which is a protease inhibitor is filtered through glomeruli, and reabsorbed by proximal tubuli, and degraded. Some studies have demonstrated superiority of plasma cystatin C over creatinine in the prediction of glomerular filtration rate. [2, 3] Recent studies have demonstrated that cystatin-C is not only a sensitive biomarker for renal dysfunction, but it is also associated with insulin resistance, and obesity. Recently, cystatin-C has been shown to predict type 2 diabetes. [4] Besides in "Western New York" health study, higher cystatin C level has been shown to be a predictive factor in the progression from normal fasting blood glucose to prediabetes. [5] In this study we aimed to evaluate the association between cystatin-C levels with anthropometric measurements, and insulin resistance in prediabetic, and diabetic patients.
MATERIAL AND METHODS
Patients with type 2 diabetes (n=25), prediabetes (n=17), and 24 healthy controls were included in the study. The study protocol was approved by the Ethics Committee of Hacettepe University School of Medicine. Impaired glucose tolerance was accepted as prediabetes. 
RESULTS

Study population consisted of 25 (M/F: 7/18) diabetic, 17
(M/F: 6/11), prediabetic patients, and 24 (M/F: 2/22) control subjects. Basic demographic, and laboratory values of the participants were presented in Table 1 . Serum cystatin C levels in control, prediabetic, and diabetic groups were 0.93±0.13, 0.89±0.16, and 0.96±0.16 mg/L, respectively (p=0.311). Cystatin C levels were comparable between female, and male participants. BMI, waist, and hip circumference, and HOMA-IR values were higher in the diabetic group when compared with the control group (p<0.05). Smoking status did not differ between groups (p=0.49). Any intergroup difference was not detected as for systolic, and diastolic blood pressure measurements (p=0.33, and p=0.51, respectively). A significant intergroup difference did not exist as for creatinine levels (p=0.25). When adjusted for age, and gender, cystatin C levels in prediabetic patients correlated with BMI, and HOMA-IR (p=0.039, and p<0.05, respectively).
DISCUSSION
This study has demonstrated the presence of a significant correlation between cystatin C levels, BMI, and HOMA-IR values in the prediabetic group. Reutens et al. have revealed that cystatin C is an independent predictor of diabe- tes in patients with larger waist circumference, increased fat mass, and insulin resistance. [6] In this cohort study, use of cystatin C could predict risk of diabetes better in the group with only central adiposity, and insulin resistance. However this correlation did not exist in patients with decreased fat mass. In the Framingham Offspring study a correlation between cystatin C levels, and BMI was found. [7] Cystatin C is released in higher concentration in omentum, and subcutaneous fat tissue [1] When compared with non-obese individuals two or three times higher amounts of cystatin C secretion were demonstrated from adipose tissue explants. [1] This finding suggest the presence of a probable interplay between cystatin C, and cathepsins playing a role in adipogenesis. [8] In obesity many biocative molecules released from adipose tissue may be responsible from the development of cardiovascular disease, and disordered homeostasis of glucose.Cathepsin family (cathepsin K, L, and S) are newly discovered potential molecules. Inhibition of cathepsins may decrease cardiovascular risk. Increased serum cystatin C in obesity may have a protective role through inhibition of cathepsin production. [8] Some studies cited in the literature have indicated that cystatin C might be a predictor of metabolic syndrome. [9] [10] [11] Apart from obesity, inflammation, and oxidative stress may be other etiologic factors which induce increases in cystatin-C levels. Induction of cystatin C mRNA, and protein synthesis by oxidative stress has been demonstrated in many studies. [11] The relationship between renal dysfunction defined with decreased glomerular filtration rate (GFR), and development of diabetes has been demonstrated. [12] This condition might be related to insulin resistance, [13] increased renal glukoneogenesis, [14] endothelial dysfunction and/or chronic inflammation, oxidative stress [14, 15] and activation of the renin-angiyotensin system. [16] In the prediction of the presence of early renal dysfunction serum cystatin C has been thought to be more definitive parameter than serum creatinine. [17] [18] [19] In recent investigations, the correlation between cystatin C, and obesity, hypertension, and insulin resistance which is closely related to diabetes has been suggested. [10] In our study cystatin C levels were comparable in diabetic, prediabetic, and control groups, and we have also demonstrated a positive correlation between cystatin C levels, BMI, and insulin resistance in the prediabetic group.
Scarce number of patients in groups constitute a limitation of this study. This cross-sectional study does not indicate the presence of cause-effect relationship. Therefore prospective studies are needed to clarify this issue.
A complex relationship exists between adiposity, cystatin C, and glycemic homeostasis. It is not absolutely certain whether cystatin C can be a predictive biomarker for impaired glucose tolerance, and developing diabetes. Further studies which will clarify, and evaluate this complex issue are needed. 
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